VYNT News and Press, Vyant Bio Inc. From 11/04/21

Evaxion Biotech (NASDAQ:EVAX) +219%. TDH Holdings (NASDAQ:PETZ) +66%. NeoPhotonics NPTN +35% on Q3 earnings. QuinStreet QNST +26% on Q1 earnings. Artelo Biosciences (NASDAQ:ARTL) +22%. Concert Pharmaceuticals CNCE +25% signs agreement to raise $65M financing Cros...

Cherry Hill, N.J., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company identifying small and large molecule therapeutics to treat central nervous system (CNS) and oncology-relate...

Engagement will combine MASORI’ s global platforms and commercial experience in Japan to identify partnerships t hat leverage Vyant Bio’s advanced analytics and complex human-derived biology to drive drug discovery ...

The following slide deck was published by Vyant Bio, Inc. in conjunction with this event. For further details see: Vyant Bio (VYNT) Investor Presentation - Slideshow

Cherry Hill, N.J., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or the “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large molecule therapeutics to treat central nervous system (&...

CDKL5 Deficiency Disorder (“CDD”) is a severe neurodevelopmental epileptic encephalopathy disorder with no effective treatments or cure Collaboration creates opportunities to identify, validate, and progress new medicines for CDD more rapidly and at a lower cost by deris...

Vyant Bio, Inc. (VYNT) Q2 2021 Earnings Conference Call August 16, 2021 04:30 AM ET Company Participants Jay Roberts - Chief Executive Officer Andy LaFrence - Chief Financial Officer Conference Call Participants Robert LeBoyer - Noble Capital Ben Haynor - Alliance Global Partners Presentation...

Vyant Bio (NASDAQ:VYNT): Q2 GAAP EPS of -$0.14. Revenue of $1.9M (+31.0% Y/Y) Press Release For further details see: Vyant Bio reports Q2 results

Strategic Highlights Received an issued US Patent titled “ High Throughput Optical Assay of Human Mixed Cell Population Spheroids ” by the United States Patent and Trademark Office (USPTO). The patent covers the use of spheroids and organoids for drug d...

CHERRY HILL, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large molecule therapeutics to treat central nervous system (CNS) and onc...